AZD-9742
- Generic Name
- AZD-9742
Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT01154621
- Locations
- 🇺🇸
Research Site, Springfield, Missouri, United States
Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2010-05-17
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT01124760
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 35
- Registration Number
- NCT01114152
- Locations
- 🇺🇸
Research Site, Glendale, California, United States
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2012-06-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT01064388
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects
- First Posted Date
- 2009-12-11
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT01030224
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath